TABLE 2.
gcIFN-20 antimicrobial activity against MDR bacteria
| MDR bacterial strain | MIC (μg/mL) |
MBC (μg/mL) |
MBC90 (μg/mL) |
G+/G− |
|---|---|---|---|---|
| Escherichia coli (ATCC 35218)a | 32 | 64 | 16 | G− |
| Escherichia coli (1103) | 32 | 32 | 8 | G− |
| Escherichia coli (1205) | 32 | 32 | 8 | G− |
| Escherichia coli (1306) | 32 | 64 | 16 | G− |
| Escherichia coli (PCN033)b | 32 | 64 | 16 | G− |
| Escherichia coli (RS218)b | 32 | 32 | 8 | G− |
| Salmonella enterica (S17) | 32 | 32 | 8 | G− |
| Klebsiella pneumoniae (K13) | 32 | 64 | 16 | G− |
| Staphylococcus aureus (ATCC 43300)a | 16 | 16 | 4 | G+ |
| Streptococcus suis (1504) | 8 | 16 | 2 | G+ |
a
Indicates typical drug resistant strain, not MDR.
b
Indicates clinical ExPEC. RS218 is not MDR.